BETHESDA, Md., March 7, 2012 (CRWENewswire) -- Spherix Incorporated (NASDAQ: SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of [...]

SURFAXIN is the First FDA-Approved Synthetic, Peptide-Containing Surfactant Conference Call Tomorrow at 10 a.m. EST WARRINGTON, Pa., March 6, 2012 (CRWENewswire) -- Discovery Laboratories, Inc. (NAS [...]

  - Consolidated service revenue of $333.2 million grew 9.5% year-over-year - GAAP operating margin of 6.8%; adjusted operating margin of 7.1% excluding net restructuring charges of $1.2 mi [...]

  Readies IND Filing BETHESDA, MD, Jan 11, 2012 (CRWENEWSWIRE) -- Spherix Incorporated (NASDAQ:SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and athero [...]

FREE Daily Stock Alerts From Stock-PR.com   SDIX™ (NASDAQ: SDIX), recently announced that it has successfully completed its previously announced sale of the assets of its water quali [...]

Results to Be Presented Wednesday, October 26, at AAPS National Meeting in Washington, DC   BETHESDA, MD, Oct. 24, 2011 (CRWENEWSWIRE) -- Spherix Incorporated (NASDAQ:SPEX) -- an innovator in [...]

FREE Daily Stock Alerts From Stock-PR.com     Seattle Genetics Inc. (NASDAQ:SGEN) recently announced that the U.S. Food and Drug Administration (FDA) has granted accelerated appro [...]

  VANCOUVER, British Columbia--(CRWENEWSWIRE)-- ProtoKinetix (OTCBB:PKTX.OB) (www.protokinetix.com), a biotechnology company that has developed and patented a family of synthetic anti-aging g [...]

Stock-PR Reporting FREE Daily Stock Alerts From Stock-PR.com ________________________________________ Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) is a biopharmaceutical company He [...]

FREE Daily Stock Alerts From Stock-PR.com   Cal Dive International Inc. (NYSE:DVR) reported a net loss for fiscal 2010 of $315.8 million and $3.47 per diluted share. This compares to net [...]